Ascendis Pharma A/S executive Bodenhoff Mads exercised Options for 3,000 shares at $110 per share on September 8, 2026, then sold 3,000 shares at $270.19 each. The transactions left Mads with 0 shares and 687 derivative securities, while representing 100.0% of prior share holdings and 81.4% of prior derivative securities holdings.

Key Highlights

  • Bodenhoff Mads sold 3,000 Ascendis Pharma A/S shares at $270.19 apiece on September 8, 2026.
  • The option exercise used transaction code M, while the share sale used code S.
  • The sale represented about 100.0% of Mads’s prior shareholding, while the derivative-security transaction represented about 81.4% of prior derivative holdings.

Ascendis Pharma A/S (NASDAQ: ASND) executive Bodenhoff Mads exercised options covering 3,000 shares at $110 per share on September 8, 2026. The transactions left Mads with 0 shares and 687 derivative securities after the activity.

$270.19 Share Sale Follows Option Exercise

Mads also sold 3,000 Ascendis Pharma A/S shares for $270.19 per share on the same date. The derivative-security transaction involved 3,000 securities. The exercise price for the shares was $110 per share. Ascendis Pharma A/S was named in both the share transaction and the derivative-security transaction.

Ownership Percentages After the Transactions

The 3,000-share option exercise represented about 100.0% of Mads’s resulting share holding. The 3,000 derivative-security transaction represented about 81.4% of Mads’s prior derivative securities holding. Following the derivative-security transaction, Mads owned 687 derivative securities.